BRILIQUE

This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Lithuania, Netherlands, Poland, Romania, Tunisia, United Kingdom

Active ingredients

The drug BRILIQUE contains one active pharmaceutical ingredient (API):

1 Ticagrelor UNII GLH0314RVC - TICAGRELOR

Ticagrelor is an oral, direct acting, selective and reversibly binding P2Y12 receptor antagonist that prevents ADP-mediated P2Y12 dependent platelet activation and aggregation. Since platelets participate in the initiation and/or evolution of thrombotic complications of atherosclerotic disease, inhibition of platelet function has been shown to reduce the risk of CV events such as death, MI or stroke. Read about Ticagrelor

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
BRILIQUE Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B01AC24	Ticagrelor	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AC Platelet aggregation inhibitors excl. heparin
Discover more medicines within B01AC24

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1506574, 1506585, 1506596, 1506608, 1506619, 1506620, 1712023, 1712034, 1712045, 1712067, 1712078, 1746828, 1746839, 1746840, 1787115
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 10655004, 10655006, 110655009, 110655013
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 111840, 382207, 419730, 447047, 579515
Country: FR	Base de données publique des médicaments	Identifier(s): 61958462, 64746646
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 182904, 299803, 324477, 346721, 374309, 376220, 379803, 381214, 399690
Country: IE	Health Products Regulatory Authority	Identifier(s): 17964, 26100, 26102
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1057918, 1057919, 1057920, 1057921, 1057922, 1057923, 1080255, 1080256, 1080257, 1080258, 1080259, 1083154, 1083155, 1083156
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 130680, 167762, 97446
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100236165, 100370811, 100407709
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W56291001, W56291002, W56291003, W56291004, W56291005, W56291006, W62794001
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 8233041